This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cosette Pharmaceuticals, Inc. Upon close, Cosette will market 12 patent-protected products focused on womens health and dermatology, including leading brands such as Rhofade (oxymetazoline topical)and several programs in clinical development. is acquiring Mayne Pharma. share for a total consideration of approximately USD $430 Million.
Her work has been featured in international publications including New York Times and Chemical & Engineering News John's Slides John Stanton comes from a background of 60 years of experience in the pharmaceutical and health care industries, mostly spent in R & D related roles. Carl presented at the Sunscreen E-Summit on behalf of DSM.
Sun Pharma is picking up all the shares in Taro Pharmaceuticals that it doesn’t already own. “Over the years, with Sun Pharma’s strategic interventions, Taro has remained a key player in the generic dermatology market in a challenging environment,” says Dilip Shanghvi, Managing Director of Sun Pharma, in a press release.
Eva holds a Master’s Degree in Communications & Marketing from Paris II Assas University. Her current research is on the economic uses of plants/fungi, in particular their potential as pharmaceutical leads, especially antibiotics, as well as uses in over-the-counter products such as cosmetics. GRI, SASB, CDP). GRI, SASB, CDP).
This is a simply enormous database of every cosmetic formulation on the market along with its pack copy. This is an idea that has been adopted from the pharmaceutical industry where it has been going on for a long time. So the products from big, medium sized companies are likely to be both legal and completely safe.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content